Sussex Research Laboratories Inc. will be closed from December 24, 2021 (Christmas Eve) to January 3rd, 2022. Thank you to our wonderful customers for your business. Happy Holidays & All the Best in 2022!

Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH

Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH molecular structure


SKUPack SizeAvailabilityPriceQuantity
GA131000-25MG25mgIn StockUS$325.00
GA131000-100MG100mgIn StockUS$750.00
GA131000-250MG250mgIn StockUS$1,600.00
GA131000-500MG500mgIn StockUS$2,900.00

Product Details

Name Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH
Product No.GA131000
Synonym(s) Tn Epitope (Threonine); Tn Antigen (Threonine, Fmoc, Peracetylated); Fmoc-Thr(α-D-GalNAc(Ac)₃)-OH; Fmoc-Thr(alpha-D-GalNAc(Ac)₃)-OH; N-α-Fmoc-O-β-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine; N-(9-fluorenylmethoxycarbonyl)-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
CategoryGlycoamino AcidsThreonine
CAS No.116783-35-8
Molecular Weight670.66
Availability in BulkYes
Purity>95% (HPLC)
DescriptionTumor-Associated Carbohydrate Antigen (TACA). Tn is a truncated O-glycosylated core determinant with structure: GalNAcα-O-Ser/Thr. In normal Mamalian cells, the Tn determinant is masked by larger glycan residues. Once unmasked, Tn serves as an important recognition element, mediating several cell-cell interactions. As such, Tn is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered Tn a prime target for cancer immunotherapy.
CommentsN-Acetyl-D-Galactosamine; O-Link; Monosaccharide; Threonine; Blocked; Amino Acid; Ac
ReferencesT. Ju, V.I. Otto and R.D. Cummings Angew. Chem. Int. Ed. 2011, 50, 1770 – 1794
Datasheet(s)GA131000_COA.pdf (84.002 KB)
‹ Back to Catalogue